| Old Articles: <Older 29681-29690 Newer> |
|---|
 |
The Motley Fool
April 16, 2008
Toby Shute |
This Rail's Anything but Frail Corn, coal, and other commodities fuel rail operator CSX's strong results.   |
The Motley Fool
April 16, 2008
Brian Orelli |
Johnson & Johnson Chugs Along Strong growth, mostly from the weak dollar, fails to excite Johnson & Johnson's investors. |
The Motley Fool
April 16, 2008
Morgan Housel |
A House-Poor Quarter for WaMu Just days after announcing plans to raise $7 billion in new capital, slashing its dividend, and rebuffing a preliminary buyout offer from JPMorgan Chase, the Seattle-based savings and loan posts very ugly quarterly earnings. |
The Motley Fool
April 16, 2008
Brian Lawler |
Alpharma's Soothing Guidance Alpharma lowers its financial guidance for 2008. Investors, take note. |
The Motley Fool
April 16, 2008
Tim Beyers |
A Scary Time for Stocks? Is it a scary time for stocks if there is no insider trading? Follow the CEOs. They've got better information than most insiders do, and, consequently, their buys and sells frequently presage market movements. |
The Motley Fool
April 16, 2008
Ryan Fuhrmann |
MEDTOX Fails the Test The Motley Fool - MEDTOX posted a weak quarter from a tough job market. |
The Motley Fool
April 16, 2008
Brian Lawler |
Cephalon Convinces the Continent The pharmaceutical's lead pain drug gets approved for marketing in Europe. |
The Motley Fool
April 16, 2008
Rich Duprey |
5 All-Star Stocks When top-notch investors back a stock, you might want to give it more consideration. |
The Motley Fool
April 16, 2008
Tom Hutchinson |
USB: What Credit Crisis? So far, US Bancorp has incurred very minor wounds in the midst of an industry bloodbath. |
The Motley Fool
April 16, 2008
Anand Chokkavelu |
Inside Infosys: A Chat With the CFO A conversation with Vibin Balakrishnan, Infosys' CFO, who answers some of our post-earnings questions. |
| <Older 29681-29690 Newer> Return to current articles. |
